WEST PHARMACEUTICAL SERVICES, INC. Other Executive Compensation Disclosures
Every other executive-compensation XBRL fact the company filed (policies, award timing, footnotes, adjustments), newest first. Long text is shortened; the filing has the full text.
- 2026-07-23: Disclosure Non Rule10b51Arr Adopted; Period 2026-04-01..2026-06-30; Value No.
- 2026-07-23: Disclosure Non Rule10b51Arr Terminated; Period 2026-04-01..2026-06-30; Value No.
- 2026-07-23: Disclosure Rule10b51Arr Terminated; Period 2026-04-01..2026-06-30; Value No.
- 2026-04-23: Disclosure Non Rule10b51Arr Adopted; Period 2026-01-01..2026-03-31; Value No.
| Filed | Disclosure | Qualifiers | Period | Value |
|---|---|---|---|---|
| 2026-07-23 10-Q | Non Rule10b51Arr Adopted | 2026-04-01..2026-06-30 | No | |
| 2026-07-23 10-Q | Non Rule10b51Arr Terminated | 2026-04-01..2026-06-30 | No | |
| 2026-07-23 10-Q | Rule10b51Arr Terminated | 2026-04-01..2026-06-30 | No | |
| 2026-04-23 10-Q | Non Rule10b51Arr Adopted | 2026-01-01..2026-03-31 | No | |
| 2026-04-23 10-Q | Non Rule10b51Arr Terminated | 2026-01-01..2026-03-31 | No | |
| 2026-04-23 10-Q | Rule10b51Arr Terminated | 2026-01-01..2026-03-31 | No | |
| 2026-03-12 DEF 14A | Insider Trading Policies Proc Adopted | 2025-01-01..2025-12-31 | Yes | |
| 2026-03-12 DEF 14A | Pay versus Performance Table | 2025-01-01..2025-12-31 | Average Summary Summary Compensation Average Value of Initial Fixed $100 Compensation Table Compensation Investment Based on: Ta… | |
| 2026-03-12 DEF 14A | Named Executive Officers Footnote | 2025-01-01..2025-12-31 | (1) For each year represented, our PEO and NEOs were as follows: Officer 2025 2024 2023 2022 2021 PEO Eric M. Green Eric M. Green Eric M. Green Eric M. Green Eric M. Green NEO Robert W. McMahon Bernard J. Birkett Bernard J. Birkett Bernard J. Birkett Bernard J. Birkett NEO Shane A. Campbell Silj… | |
| 2026-03-12 DEF 14A | Adjustment To Non PEO NEO Compensation Footnote | 2025-01-01..2025-12-31 | (3) Compensation “Actually Paid” reflects the exclusions and inclusions of equity awards for the PEO and the other NEOs as set forth below and calculated in accordance with FASB ASC Topic 718. The valuation methodologies and assumptions used to calculate Compensation “Actually Paid” are based on our… | |
| 2026-03-12 DEF 14A | Adjustment To PEO Compensation Footnote | 2025-01-01..2025-12-31 | (3) Compensation “Actually Paid” reflects the exclusions and inclusions of equity awards for the PEO and the other NEOs as set forth below and calculated in accordance with FASB ASC Topic 718. The valuation methodologies and assumptions used to calculate Compensation “Actually Paid” are based on our… | |
| 2026-03-12 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsInSummryCompstnTblForAplblYr; ExecutiveCategory: Peo | 2021-01-01..2021-12-31 | -$5.50M |
| 2026-03-12 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsInSummryCompstnTblForAplblYr; ExecutiveCategory: Peo | 2022-01-01..2022-12-31 | -$6.00M |
| 2026-03-12 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsInSummryCompstnTblForAplblYr; ExecutiveCategory: Peo | 2023-01-01..2023-12-31 | -$6.50M |
| 2026-03-12 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsInSummryCompstnTblForAplblYr; ExecutiveCategory: Peo | 2024-01-01..2024-12-31 | -$6.80M |
| 2026-03-12 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsInSummryCompstnTblForAplblYr; ExecutiveCategory: Peo | 2025-01-01..2025-12-31 | -$4.44M |
| 2026-03-12 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsInSummryCompstnTblForAplblYr; ExecutiveCategory: NonPeoNeo | 2021-01-01..2021-12-31 | -$762.61K |
| 2026-03-12 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsInSummryCompstnTblForAplblYr; ExecutiveCategory: NonPeoNeo | 2022-01-01..2022-12-31 | -$987.60K |
| 2026-03-12 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsInSummryCompstnTblForAplblYr; ExecutiveCategory: NonPeoNeo | 2023-01-01..2023-12-31 | -$1.06M |
| 2026-03-12 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsInSummryCompstnTblForAplblYr; ExecutiveCategory: NonPeoNeo | 2024-01-01..2024-12-31 | -$1.10M |
| 2026-03-12 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsInSummryCompstnTblForAplblYr; ExecutiveCategory: NonPeoNeo | 2025-01-01..2025-12-31 | -$2.22M |
| 2026-03-12 DEF 14A | Adjustment To Compensation | AdjToComp: YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstd; ExecutiveCategory: Peo | 2021-01-01..2021-12-31 | $12.29M |
| 2026-03-12 DEF 14A | Adjustment To Compensation | AdjToComp: YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstd; ExecutiveCategory: Peo | 2022-01-01..2022-12-31 | $4.43M |
| 2026-03-12 DEF 14A | Adjustment To Compensation | AdjToComp: YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstd; ExecutiveCategory: Peo | 2023-01-01..2023-12-31 | $7.67M |
| 2026-03-12 DEF 14A | Adjustment To Compensation | AdjToComp: YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstd; ExecutiveCategory: Peo | 2024-01-01..2024-12-31 | $6.44M |
| 2026-03-12 DEF 14A | Adjustment To Compensation | AdjToComp: YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstd; ExecutiveCategory: Peo | 2025-01-01..2025-12-31 | $5.74M |
| 2026-03-12 DEF 14A | Adjustment To Compensation | AdjToComp: YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstd; ExecutiveCategory: NonPeoNeo | 2021-01-01..2021-12-31 | $1.51M |
| 2026-03-12 DEF 14A | Adjustment To Compensation | AdjToComp: YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstd; ExecutiveCategory: NonPeoNeo | 2022-01-01..2022-12-31 | $734.31K |
| 2026-03-12 DEF 14A | Adjustment To Compensation | AdjToComp: YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstd; ExecutiveCategory: NonPeoNeo | 2023-01-01..2023-12-31 | $1.25M |
| 2026-03-12 DEF 14A | Adjustment To Compensation | AdjToComp: YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstd; ExecutiveCategory: NonPeoNeo | 2024-01-01..2024-12-31 | $1.04M |
| 2026-03-12 DEF 14A | Adjustment To Compensation | AdjToComp: YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstd; ExecutiveCategory: NonPeoNeo | 2025-01-01..2025-12-31 | $2.65M |
| 2026-03-12 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrs; ExecutiveCategory: Peo | 2021-01-01..2021-12-31 | $19.19M |
| 2026-03-12 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrs; ExecutiveCategory: Peo | 2022-01-01..2022-12-31 | -$13.18M |
| 2026-03-12 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrs; ExecutiveCategory: Peo | 2023-01-01..2023-12-31 | $3.05M |
| 2026-03-12 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrs; ExecutiveCategory: Peo | 2024-01-01..2024-12-31 | -$2.83M |
| 2026-03-12 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrs; ExecutiveCategory: Peo | 2025-01-01..2025-12-31 | -$2.83M |
| 2026-03-12 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrs; ExecutiveCategory: NonPeoNeo | 2021-01-01..2021-12-31 | $2.24M |
| 2026-03-12 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrs; ExecutiveCategory: NonPeoNeo | 2022-01-01..2022-12-31 | -$1.60M |
| 2026-03-12 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrs; ExecutiveCategory: NonPeoNeo | 2023-01-01..2023-12-31 | $416.67K |
| 2026-03-12 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrs; ExecutiveCategory: NonPeoNeo | 2024-01-01..2024-12-31 | -$462.31K |
| 2026-03-12 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrs; ExecutiveCategory: NonPeoNeo | 2025-01-01..2025-12-31 | -$301.48K |
| 2026-03-12 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYr; ExecutiveCategory: Peo | 2021-01-01..2021-12-31 | -$346.78K |
| 2026-03-12 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYr; ExecutiveCategory: Peo | 2022-01-01..2022-12-31 | -$5.10M |
| 2026-03-12 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYr; ExecutiveCategory: Peo | 2023-01-01..2023-12-31 | $3.37M |
| 2026-03-12 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYr; ExecutiveCategory: Peo | 2024-01-01..2024-12-31 | $47.29K |
| 2026-03-12 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYr; ExecutiveCategory: Peo | 2025-01-01..2025-12-31 | -$1.50M |
| 2026-03-12 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYr; ExecutiveCategory: NonPeoNeo | 2021-01-01..2021-12-31 | $87.14K |
| 2026-03-12 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYr; ExecutiveCategory: NonPeoNeo | 2022-01-01..2022-12-31 | -$553.60K |
| 2026-03-12 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYr; ExecutiveCategory: NonPeoNeo | 2023-01-01..2023-12-31 | $475.01K |
| 2026-03-12 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYr; ExecutiveCategory: NonPeoNeo | 2024-01-01..2024-12-31 | $2.31K |
| 2026-03-12 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYr; ExecutiveCategory: NonPeoNeo | 2025-01-01..2025-12-31 | -$156.63K |
| 2026-03-12 DEF 14A | Adjustment To Compensation | AdjToComp: AggtChngPnsnValInSummryCompstnTblForAplblYr; ExecutiveCategory: Peo | 2021-01-01..2021-12-31 | -$5.64K |
| 2026-03-12 DEF 14A | Adjustment To Compensation | AdjToComp: AggtChngPnsnValInSummryCompstnTblForAplblYr; ExecutiveCategory: Peo | 2022-01-01..2022-12-31 | -$119.83K |
| 2026-03-12 DEF 14A | Adjustment To Compensation | AdjToComp: AggtChngPnsnValInSummryCompstnTblForAplblYr; ExecutiveCategory: Peo | 2023-01-01..2023-12-31 | -$22.73K |
| 2026-03-12 DEF 14A | Adjustment To Compensation | AdjToComp: AggtChngPnsnValInSummryCompstnTblForAplblYr; ExecutiveCategory: Peo | 2024-01-01..2024-12-31 | -$7.25K |
| 2026-03-12 DEF 14A | Adjustment To Compensation | AdjToComp: AggtChngPnsnValInSummryCompstnTblForAplblYr; ExecutiveCategory: Peo | 2025-01-01..2025-12-31 | -$47.80K |
| 2026-03-12 DEF 14A | Adjustment To Compensation | AdjToComp: AggtChngPnsnValInSummryCompstnTblForAplblYr; ExecutiveCategory: NonPeoNeo | 2024-01-01..2024-12-31 | -$578.00 |
| 2026-03-12 DEF 14A | Adjustment To Compensation | AdjToComp: AggtChngPnsnValInSummryCompstnTblForAplblYr; ExecutiveCategory: NonPeoNeo | 2025-01-01..2025-12-31 | -$1.00K |
| 2026-03-12 DEF 14A | Adjustment To Compensation | AdjToComp: PnsnAdjsPrrSvcCst | 2025-01-01..2025-12-31 | $0.00 |
| 2026-03-12 DEF 14A | Adjustment To Compensation | AdjToComp: VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYr | 2025-01-01..2025-12-31 | $0.00 |
| 2026-03-12 DEF 14A | Adjustment To Compensation | AdjToComp: FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYr | 2025-01-01..2025-12-31 | $0.00 |
| 2026-03-12 DEF 14A | Equity Valuation Assumption Difference Footnote | 2025-01-01..2025-12-31 | Equity Valuations: Stock option grant date fair values are calculated based on the Black-Scholes option pricing model as of date of grant. Adjustments have been made using stock option fair values as of each measurement date using the stock price as of the measurement date and updated assumptions (i… | |
| 2026-03-12 DEF 14A | Peer Group Issuers Footnote | 2025-01-01..2025-12-31 | (4) Reflects total shareholder return indexed to $100 per share for West and the S&P 500 Health Care Index (“Peer Group”), which is the industry line peer group reported in our 2025 Form 10-K. For each reporting year, TSR is measured as follows: Reporting Year Beginning End Number of Years 2… | |
| 2026-03-12 DEF 14A | Non Gaap Measure Description | Measure: 1 | 2025-01-01..2025-12-31 | (5) Pursuant to Item 402(v), we determined West’s revenue to be the most important financial performance measure used to link Company performance to Compensation “Actually Paid” to our PEO and other NEOs, and this is designated as our Company-Selected Measure for 2025. This performance measure may n… |
| 2026-03-12 DEF 14A | Tabular List Table | 2025-01-01..2025-12-31 | Listed below are the financial and non-financial performance measures which in our assessment represent the most important performance measures we used during 2025 to link Compensation “Actually Paid” to our PEO and other NEOs to company performance. Most Important Performance Measures Revenue Earni… | |
| 2026-03-12 DEF 14A | Total Shareholder Return Vs Peer Group | 2025-01-01..2025-12-31 | | |
| 2026-03-12 DEF 14A | Compensation Actually Paid Vs Total Shareholder Return | 2025-01-01..2025-12-31 | | |
| 2026-03-12 DEF 14A | Compensation Actually Paid Vs Net Income | 2025-01-01..2025-12-31 | | |
| 2026-03-12 DEF 14A | Compensation Actually Paid Vs Company Selected Measure | 2025-01-01..2025-12-31 | | |
| 2026-03-12 DEF 14A | Award Timing MNPI Disclosure | 2025-01-01..2025-12-31 | As described in our CD&A, annual equity awards granted to NEOs are normally made once per year, although we may also make mid-year grants to new NEO hires. The Company’s policy on equity grants contains rules on determining (1) the grant date of equity awards (at least two business days foll… | |
| 2026-03-12 DEF 14A | Award Timing Method | 2025-01-01..2025-12-31 | As described in our CD&A, annual equity awards granted to NEOs are normally made once per year, although we may also make mid-year grants to new NEO hires. The Company’s policy on equity grants contains rules on determining (1) the grant date of equity awards (at least two business days foll… | |
| 2026-03-12 DEF 14A | Award Timing How MNPI Considered | 2025-01-01..2025-12-31 | The Company’s policy on equity grants contains rules on determining (1) the grant date of equity awards (at least two business days following the release of our annual results for the preceding fiscal year, so that the awards are not made until such material nonpublic information has been disclosed … | |
| 2026-03-12 DEF 14A | Award Timing Predetermined | 2025-01-01..2025-12-31 | Yes | |
| 2026-03-12 DEF 14A | Award Timing MNPI Considered | 2025-01-01..2025-12-31 | No | |
| 2026-03-12 DEF 14A | Awards Close To MNPI Disclosure Table | 2025-01-01..2025-12-31 | Percentage change in the closing market price of the securities underlying the award between the trading day ending immediately prior to Number of the disclos… | |
| 2026-03-12 DEF 14A | Awards Close To MNPI Disclosure Individual Name | Individual: EricM.Green | 2025-02-18 | Eric M. Green |
| 2026-03-12 DEF 14A | Award Undrlyg Securities | Individual: EricM.Green | 2025-02-18 | 12,149 |
| 2026-03-12 DEF 14A | Award Exrc Price | Individual: EricM.Green | 2025-02-18 | 211 |
| 2026-03-12 DEF 14A | Award Grant Date Fair Value | Individual: EricM.Green | 2025-02-18 | $1.11M |
| 2026-03-12 DEF 14A | Undrlyg Security Mkt Price Chng Pct | Individual: EricM.Green | 2025-02-18 | -5.7 |
| 2026-03-12 DEF 14A | Awards Close To MNPI Disclosure Individual Name | Individual: AnnetteF.Favorite | 2025-02-18 | Annette F. Favorite |
| 2026-03-12 DEF 14A | Award Undrlyg Securities | Individual: AnnetteF.Favorite | 2025-02-18 | 1,251 |
| 2026-03-12 DEF 14A | Award Exrc Price | Individual: AnnetteF.Favorite | 2025-02-18 | 211 |
| 2026-03-12 DEF 14A | Award Grant Date Fair Value | Individual: AnnetteF.Favorite | 2025-02-18 | $114.19K |
| 2026-03-12 DEF 14A | Undrlyg Security Mkt Price Chng Pct | Individual: AnnetteF.Favorite | 2025-02-18 | -5.7 |
| 2026-03-12 DEF 14A | Awards Close To MNPI Disclosure Individual Name | Individual: KimberlyB.Mackay | 2025-02-18 | Kimberly B. MacKay |
| 2026-03-12 DEF 14A | Award Undrlyg Securities | Individual: KimberlyB.Mackay | 2025-02-18 | 1,162 |
| 2026-03-12 DEF 14A | Award Exrc Price | Individual: KimberlyB.Mackay | 2025-02-18 | 211 |
| 2026-03-12 DEF 14A | Award Grant Date Fair Value | Individual: KimberlyB.Mackay | 2025-02-18 | $106.07K |
| 2026-03-12 DEF 14A | Undrlyg Security Mkt Price Chng Pct | Individual: KimberlyB.Mackay | 2025-02-18 | -5.7 |
| 2026-03-12 DEF 14A | Awards Close To MNPI Disclosure Individual Name | Individual: BernardJ.Birkett | 2025-02-18 | Bernard J. Birkett |
| 2026-03-12 DEF 14A | Award Undrlyg Securities | Individual: BernardJ.Birkett | 2025-02-18 | 4,020 |
| 2026-03-12 DEF 14A | Award Exrc Price | Individual: BernardJ.Birkett | 2025-02-18 | 211 |
| 2026-03-12 DEF 14A | Award Grant Date Fair Value | Individual: BernardJ.Birkett | 2025-02-18 | $366.95K |
| 2026-03-12 DEF 14A | Undrlyg Security Mkt Price Chng Pct | Individual: BernardJ.Birkett | 2025-02-18 | -5.7 |
| 2026-02-17 10-K | Rule10b51Arr Adopted | 2025-10-01..2025-12-31 | No | |
| 2026-02-17 10-K | Non Rule10b51Arr Adopted | 2025-10-01..2025-12-31 | No | |
| 2026-02-17 10-K | Non Rule10b51Arr Terminated | 2025-10-01..2025-12-31 | No | |
| 2026-02-17 10-K | Rule10b51Arr Terminated | 2025-10-01..2025-12-31 | No | |
| 2026-02-17 10-K | Insider Trading Policies Proc Adopted | 2025-01-01..2025-12-31 | Yes |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |